Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center.
Kim
S-Y
SY
Cho
S-G
SG
Cho
B-S
BS
Kim
M-S
MS
Eom
K-S
KS
Kim
Y-J
YJ
Kim
H-J
HJ
Lee
S
S
Min
C-K
CK
Kim
D-W
DW
Lee
J-W
JW
Min
W-S
WS
D000328:Adult; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000473:pathology; D010865:Pilot Projects; D012008:Recurrence; D016879:Salvage Therapy / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D001374:Azacitidine